Literature DB >> 8304058

The effect of acetylcholinesterase inhibitor (SDZ ENA 713) for r-CBF and focal cerebral ischaemia.

S Tsujimoto1, T Sakaki, T Morimoto, M Tominaga.   

Abstract

The purpose of the present study was to examine the effect of Acetylcholinesterase inhibitor (AChEI) on r-CBF (group A) and its protecting effect on focal ischaemic cell damage (group B). The pial arterial diameter and the r-CBF were measured with a width analyzer and with a laser Doppler flowmeter through a cat cranial window on the ectosylvian gyrus. The ischaemic area was measured histologically. We used intravenous injection of AChEI([-])(S)-N-ethyl-3-[(1-dimethyl- amino)ethyl]-N-methyl-phenylcarbamate, SDZENA 713, Sands Pharmacy) to block AChE. Twenty minutes after injection AChEI (0.6 mg/kg) the pial arteriole dilated 108.5 +/- 1.8% and the r-CBF increased 115.4 +/- 2.6%. The pial arteriole dilated maximally to 137.6 +/- 6.5% at 120 minutes after injection and the r-CBF increased maximally to 137.1 +/- 19.5% at 60 minutes after injection. The protecting effect was evaluated using cats and 1 hour of occlusion of the middle cerebral artery (MCA). Twenty minutes after injection of AChEI, the pial arteriole dilated to 116.7 +/- 2.4% and the r-CBF increased to 111.9 +/- 2.6% significantly. During MCA occlusion the r-CBF decreased to 24.7-41.4% in group B and 25.1-32.6% in sham group (group C). The pial arteriole dilated 145.0-184.0% in group C and 150.7-171.6% in group B during MCA occlusion and 30 minutes after reperfusion the pial arteriole returned to 120.0 +/- 3.3% in group C and 123.4 +/- 11.3% in group B. There were no significant changes in the r-CBF and the vessel diameter between group B and C during the 2 hours after reperfusion.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8304058     DOI: 10.1007/BF01401134

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  25 in total

1.  Formation of free choline in brain tissue during in vitro energy deprivation.

Authors:  B Djuricic; S R Olson; H M Assaf; T S Whittingham; W D Lust; L R Drewes
Journal:  J Cereb Blood Flow Metab       Date:  1991-03       Impact factor: 6.200

2.  Focal ischemia enhances choline output and decreases acetylcholine output from rat cerebral cortex.

Authors:  O U Scremin; D J Jenden
Journal:  Stroke       Date:  1989-01       Impact factor: 7.914

Review 3.  Phospholipases, lysophospholipases, and lipases and their involvement in various diseases.

Authors:  A A Farooqui; W A Taylor; L A Horrocks
Journal:  Neurochem Pathol       Date:  1987-10

Review 4.  The source of choline for acetylcholine synthesis in brain.

Authors:  J J Freeman; D J Jenden
Journal:  Life Sci       Date:  1976-10-01       Impact factor: 5.037

Review 5.  Problems in the organization and control of acetylcholine synthesis in brain neurons.

Authors:  S Tucek
Journal:  Prog Biophys Mol Biol       Date:  1984       Impact factor: 3.667

6.  Effects of oxygen radicals on cerebral arterioles.

Authors:  E P Wei; C W Christman; H A Kontos; J T Povlishock
Journal:  Am J Physiol       Date:  1985-02

7.  Degradation of phospholipid molecular species during experimental cerebral ischemia in rats.

Authors:  Y Goto; S Okamoto; Y Yonekawa; W Taki; H Kikuchi; H Handa; M Kito
Journal:  Stroke       Date:  1988-06       Impact factor: 7.914

8.  Vascular endothelial cells synthesize nitric oxide from L-arginine.

Authors:  R M Palmer; D S Ashton; S Moncada
Journal:  Nature       Date:  1988-06-16       Impact factor: 49.962

9.  Formation of unesterified choline by rat brain.

Authors:  S H Zeisel
Journal:  Biochim Biophys Acta       Date:  1985-07-09

10.  [Dynamics of extracellular acetylcholine of the gerbil striatum during cerebral ischemia monitored by intracerebral microdialysis].

Authors:  M Ueno; T Itakura; H Yokote; H Imai; T Okuno; N Komai
Journal:  No To Shinkei       Date:  1991-05
View more
  2 in total

1.  Novel polyacetylene derivatives and their inhibitory activities on acetylcholinesterase obtained from Panax ginseng roots.

Authors:  Kazuya Murata; Daiki Iida; Yoshihiro Ueno; Keiichi Samukawa; Toshihiko Ishizaka; Takeshi Kotake; Hideaki Matsuda
Journal:  J Nat Med       Date:  2016-08-27       Impact factor: 2.343

2.  Efficacy and tolerability of rivastigmine patch therapy in patients with mild-to-moderate Alzheimer's dementia associated with minimal and moderate ischemic white matter hyperintensities: A multicenter prospective open-label clinical trial.

Authors:  Kyung Won Park; Eun-Joo Kim; Hyun Jeong Han; Yong S Shim; Jae C Kwon; Bon D Ku; Kee Hyung Park; Hyon-Ah Yi; Kwang K Kim; Dong Won Yang; Ho-Won Lee; Heeyoung Kang; Oh Dae Kwon; SangYun Kim; Jae-Hyeok Lee; Eun Joo Chung; Sang-Won Park; Mee Young Park; Bora Yoon; Byeong C Kim; Sang Won Seo; Seong Hye Choi
Journal:  PLoS One       Date:  2017-08-07       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.